Related Experiment Video
Updated: May 11, 2026

In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor
E G Fischer1, M Riewald, H Y Huang
1Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Abstract:
Tissue factor (TF), the cell-surface receptor for coagulation factor VIIa, supports metastasis. Equally important for this process are (a) interactions of the TF cytoplasmic domain, which binds the mobility-enhancing actin-binding protein 280, and (b) the formation of a proteolytically active TF-VIIa complex on the tumor cell surface. In primary bladder carcinoma cells, we find that this complex localizes to the invasive edge, in proximity to tumor-infiltrating vessels that stain intensely for TF pathway inhibitor (TFPI-1), the major inhibitor of the protease activity of the complex. In culture, binding of VIIa to TF-expressing tumor cells is sufficient to allow cell adhesion, migration, and intracellular signaling on immobilized TFPI-1. Immobilized heparin, a mimic for extracellular matrix-associated proteoglycans, binds physiological concentrations of TFPI-1 in a conformation that supports TF-VIIa-dependent cell adhesion. Consistent with a functional role of TFPI-1 in complex extracellular matrices, we show that TF cooperates with integrin-mediated adhesion and migration on composite matrices that contain ligands for both integrins and the TF-VIIa complex. This study thus provides evidence for a novel mechanism of protease-supported migration that is independent of proteolytic matrix degradation but rather involves protease-dependent bridging of TF's extracellular domain to an ECM-associated inhibitor.
Insights
Tissue factor (TF) supports cancer metastasis by forming a complex with factor VIIa (TF-VIIa). This complex interacts with TF pathway inhibitor (TFPI-1) on tumor cells, promoting cell adhesion and migration.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Tissue factor (TF) is a cell-surface receptor crucial for coagulation factor VIIa (TF-VIIa) binding.
- TF signaling, particularly through its cytoplasmic domain interactions and TF-VIIa complex formation, is implicated in cancer metastasis.
- TF pathway inhibitor (TFPI-1) is a key inhibitor of the TF-VIIa complex's protease activity.
Purpose of the Study:
- To investigate the role of the TF-VIIa complex and its interaction with TFPI-1 in cancer cell migration and adhesion.
- To elucidate the mechanism by which TFPI-1 influences TF-mediated cellular processes at the tumor invasive edge.
- To explore the cooperative function of TF and integrin-mediated adhesion in complex extracellular matrices.
Main Methods:
- Localization studies of the TF-VIIa complex at the invasive edge of primary bladder carcinoma cells.
- In vitro cell culture experiments assessing adhesion, migration, and intracellular signaling of TF-expressing tumor cells on immobilized TFPI-1.
- Analysis of TF-VIIa-dependent cell adhesion on immobilized heparin mimicking extracellular matrix proteoglycans.
- Investigation of TF's role in cell migration on composite matrices containing integrin and TF-VIIa ligands.
Main Results:
- The TF-VIIa complex localizes to the invasive edge of bladder carcinoma cells, near TFPI-1-rich vessels.
- Binding of TF-VIIa to TF-expressing tumor cells facilitates cell adhesion, migration, and signaling on immobilized TFPI-1.
- Immobilized heparin enhances TF-VIIa-dependent cell adhesion by binding TFPI-1.
- TF collaborates with integrin-mediated adhesion and migration on complex extracellular matrices.
Conclusions:
- A novel mechanism of protease-supported cell migration exists, independent of matrix degradation.
- This mechanism involves protease-dependent bridging between TF's extracellular domain and ECM-associated TFPI-1.
- TF-TFPI-1 interactions play a significant role in tumor cell invasion and metastasis.
Related Concept Videos
Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
Cancer Cell Migration through Invadopodia
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...

